Replies to post #863 on Antares Pharma, Inc. (ATRS)

[Bsav88atty]

Cat,

I obviously cannot predict supply limitation issues, but based on my projected demand, I continue to stand behind my numbers. Remember that my 2014 number is significantly less than my 2015 number. And with the back half of this year to prepare for the Q1-14 launch, I strongly believe ATRS can deliver the numbers if the pricing is consistent with earlier anticipated pricing for Otrexup. The demand will surprise everyone. I also believe the company's guidance is ultra conservative.

Thanks for your question.